标题/作者	年份
Diagnosis and management of AML in adults: 2022 recommendations from an international expert panel on behalf of the ELN H Döhner, AH Wei, FR Appelbaum, C Craddock, CD DiNardo, H Dombret, ... Blood, The Journal of the American Society of Hematology 140 (12), 1345-1377	2022
Carfilzomib or bortezomib in combination with lenalidomide and dexamethasone for patients with newly diagnosed multiple myeloma without intention for immediate autologous stem-cell transplantation (ENDURANCE): a multicentre, open-label, phase 3, randomised, controlled trial SK Kumar, SJ Jacobus, AD Cohen, M Weiss, N Callander, AK Singh, ... The Lancet Oncology 21 (10), 1317-1330	2020
COVID-19 in immunocompromised patients: a systematic review of cancer, hematopoietic cell and solid organ transplant patients JA Belsky, BP Tullius, MG Lamb, R Sayegh, JR Stanek, JJ Auletta Journal of Infection 82 (3), 329-338	2021
Hematopoietic stem cell transplantation K Khaddour, CK Hana, P Mewawalla	2019
Double unrelated umbilical cord blood vs HLA-haploidentical bone marrow transplantation: the BMT CTN 1101 trial EJ Fuchs, PV O’Donnell, M Eapen, B Logan, JH Antin, P Dawson, ... Blood, The Journal of the American Society of Hematology 137 (3), 420-428	2021
The consensus from The Chinese Society of Hematology on indications, conditioning regimens and donor selection for allogeneic hematopoietic stem cell transplantation: 2021 update X Zhang, J Chen, MZ Han, H Huang, E Jiang, M Jiang, Y Lai, D Liu, ... Journal of hematology & oncology 14, 1-20	2021
National marrow donor program–sponsored multicenter, phase II trial of HLA-mismatched unrelated donor bone marrow transplantation using post-transplant cyclophosphamide BE Shaw, AM Jimenez-Jimenez, LJ Burns, BR Logan, F Khimani, ... Journal of clinical oncology 39 (18), 1971	2021
Posttransplant cyclophosphamide is associated with increased cytomegalovirus infection: a CIBMTR analysis SR Goldsmith, MB Abid, JJ Auletta, A Bashey, A Beitinjaneh, P Castillo, ... Blood, The Journal of the American Society of Hematology 137 (23), 3291-3305	2021
Allogeneic stem cell transplantation for chronic lymphocytic leukemia in the era of novel agents LE Roeker, P Dreger, JR Brown, OB Lahoud, TA Eyre, DM Brander, ... Blood advances 4 (16), 3977-3989	2020
History of hematopoietic cell transplantation: challenges and progress N Granot, R Storb Haematologica 105 (12), 2716	2020
HLA informs risk predictions after haploidentical stem cell transplantation with posttransplantation cyclophosphamide EJ Fuchs, SR McCurdy, SR Solomon, T Wang, MR Herr, D Modi, ... Blood, The Journal of the American Society of Hematology 139 (10), 1452-1468	2022
Age no bar: a CIBMTR analysis of elderly patients undergoing autologous hematopoietic cell transplantation for multiple myeloma PN Munshi, D Vesole, A Jurczyszyn, JM Zaucha, A St. Martin, O Davila, ... Cancer 126 (23), 5077-5087	2020
Is autologous transplant in relapsed DLBCL patients achieving only a PET+ PR appropriate in the CAR T-cell era? NN Shah, KW Ahn, C Litovich, Y He, C Sauter, TS Fenske, M Hamadani Blood, The Journal of the American Society of Hematology 137 (10), 1416-1423	2021
Myeloablative versus reduced-intensity conditioning for hematopoietic cell transplantation in acute myelogenous leukemia and myelodysplastic syndromes—long-term follow-up of the BMT CTN 0901 clinical trial BL Scott, MC Pasquini, M Fei, R Fraser, J Wu, SM Devine, DL Porter, ... Transplantation and cellular therapy 27 (6), 483. e1-483. e6	2021
Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant PD Lulla, S Naik, S Vasileiou, I Tzannou, A Watanabe, M Kuvalekar, ... Blood, The Journal of the American Society of Hematology 137 (19), 2585-2597	2021
Integrating CAR T-cell therapy and transplantation: comparisons of safety and long-term efficacy of allogeneic hematopoietic stem cell transplantation after CAR T-cell or chemotherapy-based complete remission in B-cell acute lymphoblastic leukemia YL Zhao, DY Liu, RJ Sun, JP Zhang, JR Zhou, ZJ Wei, M Xiong, XY Cao, ... Frontiers in Immunology 12, 605766	2021
Trends in late mortality and life expectancy after allogeneic blood or marrow transplantation over 4 decades: a blood or marrow transplant survivor study report S Bhatia, C Dai, W Landier, L Hageman, J Wu, E Schlichting, A Siler, ... JAMA oncology 7 (11), 1626-1634	2021
Relapse and disease-free survival in patients with myelodysplastic syndrome undergoing allogeneic hematopoietic cell transplantation using older matched sibling donors vs younger matched unrelated donors GSG Murthy, S Kim, ZH Hu, N Estrada-Merly, MB Abid, M Aljurf, U Bacher, ... JAMA oncology 8 (3), 404-411	2022
Nonclassical manifestations of acute GVHD R Zeiser, T Teshima Blood, The Journal of the American Society of Hematology 138 (22), 2165-2172	2021
Age is no barrier for adults undergoing HCT for AML in CR1: contemporary CIBMTR analysis JE Maakaron, MJ Zhang, K Chen, S Abhyankar, VR Bhatt, S Chhabra, ... Bone marrow transplantation 57 (6), 911-917	2022

1 - 20

计算机程序会自动估算并确定日期和引用次数。